Key Highlights

  • SBC Medical Group was trading up 26.59% at USD 6.76 on Friday, November 13, 2026, in market data, after releasing third-quarter 2026 results before the open.
  • Third-quarter Revenue rose 35% to USD 58.6 million from USD 43.4 million, while income from operations climbed 66% to USD 26.4 million, an Operating Margin of about 45%.
  • Net income attributable to the company rose 22% to USD 15.7 million, or USD 0.15 a basic share, and adjusted EBITDA rose 66% to USD 27.6 million.
  • Cash stood at USD 198.4 million on September 30, 2026, with non-GAAP net cash of USD 154 million, and the clinic network reached 293 locations, up 36 year over year.

Third-Quarter Results Land Before the Open

SBC Medical Group (NASDAQ:SBC) was trading up 26.59% at USD 6.76 on Friday, November 13, 2026, after it reported third-quarter results before the market opened. Revenue reached USD 58.6 million against USD 43.4 million a year earlier, and Net Income attributable to the company was USD 15.7 million against USD 12.8 million. Basic Earnings were USD 0.15 a share, up from USD 0.12. The company, a medical services organization that provides management support to clinics in aesthetics and other fields, listed on Nasdaq in September 2024. The screener move is the figure of record for the live session; a prior close near USD 5.34 is implied (calculated).

An Easy Comparison and a Sharper Margin

The year-ago quarter was weak, since USD 43.4 million was down about 18% from the prior year, so the 35% gain starts from a low base. Nine-month revenue rose 13% to USD 150.8 million, which implies first-half revenue of about USD 92.2 million, only slightly above the prior year (calculated). Third-quarter operating margin of about 45% and adjusted EBITDA margin of 47% show how much profit flows from each revenue dollar. Nine-month net income of USD 37.7 million was only 2% higher, so the improvement is concentrated in this quarter. The release gave no financial guidance and did not mention a dividend.

Clinic Growth, Visits and What to Watch

The network grew to 293 clinics, and trailing twelve-month patient visits reached 7.06 million, up 9%, with average spend per visit of USD 290, up 4%. Operating Cash Flow for the nine months was USD 50.2 million. Risks include whether the quarterly acceleration repeats, since the first half was roughly flat, plus dependence on Franchise and clinic activity and the absence of stated guidance. The Earnings Call was scheduled for the morning of November 13, 2026. A sharp one-day gain can retrace, and company-reported adjusted figures are not a substitute for the GAAP results.

Where Things Stand

The rally appears tied to the quarter itself. SBC Medical Group (NASDAQ:SBC) reported revenue up 35% to USD 58.6 million, Operating Income up 66% and net income up 22%, a clear step up from a weak year-ago quarter and a flat first half. Cash of USD 198.4 million adds Balance Sheet comfort. Against that, the nine-month profit gain was only 2% and no guidance was issued. Next markers are the management call commentary, the quarterly filing and whether visit and spend trends keep improving in the fourth quarter.